BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25008235)

  • 1. The Bologna criteria for the definition of poor ovarian responders: is there a need for revision?
    Ferraretti AP; Gianaroli L
    Hum Reprod; 2014 Sep; 29(9):1842-5. PubMed ID: 25008235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing the ESHRE 'poor responder' criteria in research studies: methodological implications.
    Papathanasiou A
    Hum Reprod; 2014 Sep; 29(9):1835-8. PubMed ID: 24916434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bologna criteria for poor ovarian response: the good, the bad and the way forward.
    Venetis CA
    Hum Reprod; 2014 Sep; 29(9):1839-41. PubMed ID: 24908672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria.
    Polyzos NP; Blockeel C; Verpoest W; De Vos M; Stoop D; Vloeberghs V; Camus M; Devroey P; Tournaye H
    Hum Reprod; 2012 Dec; 27(12):3481-6. PubMed ID: 22940767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI.
    Polyzos NP; Nwoye M; Corona R; Blockeel C; Stoop D; Haentjens P; Camus M; Tournaye H
    Reprod Biomed Online; 2014 Apr; 28(4):469-74. PubMed ID: 24581984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis and cost-effectiveness of IVF in poor responders according to the Bologna Criteria.
    Busnelli A; Somigliana E
    Minerva Ginecol; 2018 Feb; 70(1):89-98. PubMed ID: 28895678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel?
    Polyzos NP; Devroey P
    Fertil Steril; 2011 Nov; 96(5):1058-61.e7. PubMed ID: 22036048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria.
    Ferraretti AP; La Marca A; Fauser BC; Tarlatzis B; Nargund G; Gianaroli L;
    Hum Reprod; 2011 Jul; 26(7):1616-24. PubMed ID: 21505041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.
    Pu D; Wu J; Liu J
    Hum Reprod; 2011 Oct; 26(10):2742-9. PubMed ID: 21778283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
    Kedem A; Tsur A; Haas J; Yerushalmi GM; Hourvitz A; Machtinger R; Orvieto R
    Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study.
    La Marca A; Grisendi V; Giulini S; Sighinolfi G; Tirelli A; Argento C; Re C; Tagliasacchi D; Marsella T; Sunkara SK
    J Assist Reprod Genet; 2015 Jun; 32(6):931-7. PubMed ID: 25925345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Physiology and Definition of Poor Ovarian Response; Clinical Recommendations.
    Abu-Musa A; Haahr T; Humaidan P
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32204404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
    Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
    Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prolonging administration gonadotropin on unexpectedly poor ovarian responders undergoing in vitro fertilization.
    Wei Z; Cheng X; Li H; Cao Y; Cong L; Zhou P; Li J
    Reprod Biol Endocrinol; 2010 Mar; 8():26. PubMed ID: 20236519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study.
    Polyzos NP; De Vos M; Corona R; Vloeberghs V; Ortega-Hrepich C; Stoop D; Tournaye H
    Hum Reprod; 2013 May; 28(5):1254-60. PubMed ID: 23442756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified natural-cycle in vitro fertilization should be considered as the first approach in young poor responders.
    Kadoch IJ; Phillips SJ; Bissonnette F
    Fertil Steril; 2011 Nov; 96(5):1066-8. PubMed ID: 22036050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of theca cell function: a prerequisite to androgen or luteinizing hormone supplementation in poor responders.
    Hugues JN; Massart P; Cedrin-Durnerin I
    Fertil Steril; 2013 Feb; 99(2):333-6. PubMed ID: 23058685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clomiphene citrate challenge test versus the exogenous follicle-stimulating hormone ovarian reserve test as a single test for identification of low responders and hyperresponders to in vitro fertilization.
    Kwee J; Schats R; McDonnell J; Schoemaker J; Lambalk CB
    Fertil Steril; 2006 Jun; 85(6):1714-22. PubMed ID: 16650416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis.
    Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Baart EB; Hohmann FP; Fauser BC; Broekmans FJ
    Hum Reprod Update; 2009; 15(1):5-12. PubMed ID: 19091754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.